Mathias Chamaillard

Author PubWeight™ 78.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005 11.31
2 Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003 10.79
3 Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011 7.98
4 CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002 5.31
5 NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 2013 2.96
6 Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004 2.81
7 Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2006 2.16
8 Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A 2011 2.12
9 Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut 2012 1.97
10 Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 2006 1.63
11 Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut 2006 1.34
12 Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A 2010 1.29
13 Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One 2009 1.24
14 Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. Infect Immun 2012 1.19
15 A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages. J Biol Chem 2005 1.16
16 Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pathog 2007 1.12
17 Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 2009 1.07
18 Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 2007 1.05
19 IBD serological panels: facts and perspectives. Inflamm Bowel Dis 2007 1.04
20 Enterocyte loss of polarity and gut wound healing rely upon the F-actin-severing function of villin. Proc Natl Acad Sci U S A 2013 0.99
21 NOD2: a potential target for regulating liver injury. Lab Invest 2008 0.95
22 NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol 2006 0.95
23 Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Am J Respir Crit Care Med 2014 0.93
24 Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol 2007 0.93
25 Toll-interacting protein modulates colitis susceptibility in mice. Inflamm Bowel Dis 2014 0.89
26 Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients. Dig Dis Sci 2010 0.87
27 micro-Opioid receptor activation prevents acute hepatic inflammation and cell death. Gut 2007 0.86
28 How NOD2 mutations predispose to Crohn's disease? Microbes Infect 2007 0.86
29 Clustering of Crohn's disease within affected sibships. Eur J Hum Genet 2003 0.85
30 Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction. Am J Gastroenterol 2007 0.83
31 The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am J Physiol Gastrointest Liver Physiol 2013 0.83
32 Remote control of intestinal tumorigenesis by innate immunity. Cancer Res 2010 0.83
33 Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease. Inflamm Bowel Dis 2010 0.82
34 Functional polymorphisms in the regulatory regions of the VNN1 gene are associated with susceptibility to inflammatory bowel diseases. Inflamm Bowel Dis 2013 0.80
35 Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease. Trends Immunol 2010 0.80
36 Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation. Inflamm Bowel Dis 2014 0.79
37 Innate immunity in Crohn's disease: the reverse side of the medal. J Clin Gastroenterol 2008 0.79
38 NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007 0.78
39 Photodynamic therapy as a new treatment modality for inflammatory and infectious conditions. Expert Rev Clin Immunol 2015 0.76
40 CCL17 production by dendritic cells is required for NOD1-mediated exacerbation of allergic asthma. Am J Respir Crit Care Med 2014 0.76
41 Phagocytes migration in response to an emergency call from the microbiota. Gastroenterology 2013 0.75
42 Intestinal microbiota gives a nod to the hygiene hypothesis in type 1 diabetes. Gastroenterology 2009 0.75
43 Photodynamic therapy relieves colitis and prevents colitis-associated carcinogenesis in mice. Inflamm Bowel Dis 2015 0.75
44 NOD2 prevents emergence of disease-predisposing microbiota. Gut Microbes 2013 0.75
45 [Dysbiosis, a new medical concept]. Med Sci (Paris) 2013 0.75